In Brief: CDC calls for safer cough/cold delivery, USPlabs toes the line, Neptune disputes fine, and more
This article was originally published in The Tan Sheet
Executive Summary
CDC study calls for safer cough/cold delivery; USPlabs toes FDA line; Neptune disputes workplace safety fine; FDA postpones OTC eyewash hearing; and more In Brief.
You may also be interested in...
Investment Group Focused On Natural Wellness Acquires Plant-Based Protein Pioneer Vega
WM Partners acquires Vega plant-based nutrition brand from Danone with plans to leverage its operational experience to grow the brand and tap Vega’s distribution to expand market for its existing portfolio of brands.
GNC Supply Chain Reform Pays Dividends In DoJ Settlement From DMAA Investigation
DoJ announces a "non-prosecution agreement" that requires GNC to pay $2.25m and to cooperate in dietary supplement market investigations conducted by FDA and other federal agencies, including the current litigation against USPlabs.
More Than 100 Herbal Supplements On Recall Under Consent Decree
According to FDA's latest report on recalls, Iowa Select Herbs in September began recalling 104 supplement products, including some herbals in standard and alcohol-free varieties, two years after FDA found drug claims for its products and GMP violations at its facility.